Determination of aspirin and salicylic acid in transdermal perfusates

Calixarene-doped PVC polymeric films as size-selective optical sensors: Monitoring of salicylate in real samples

Preparation of novel salicylate-selective optical sensors (bulk optodes) was performed and applied successfully for salicylate determination in pharmaceutical formulations, Aspirin® and Aspocid®. t-butyl calix[4]arene ionophore was incorporated in a plasticized poly (vinyl-chloride) membrane containing the chromoionophore ETH5294 (O₁) or ETH7075 (O₅). The optical response to salicylate was due to size-selective extraction of salicylate from the aqueous solution to the optode bulk through formation of hydrogen bond accompanied by chromoionophore protonation, that resulted in the optical response at 680 or 540 nm for O₁ or O₅, respectively. Reliable size-selectivity was measured for salicylate over other anions; The calculated selectivity coefficients of O₅ optode were found to be: -4.4, -2.0 and - 3.7 for iodide, benzoate and perchlorate, respectively. The hydrogen bonding mechanism and selectivity pattern were ensured and explained by IR and ¹H NMR spectroscopy. For the same purpose, a molecular recognition constant of β_sal=10^0.043 was calculated using sandwich membrane method, and its small value ensured that hydrogen bonding interaction is responsible for the optode response. The detection limits of O₁ and O₅ in salicylate buffered solutions were 9.0 × 10^-5 and 8.9 × 10^-5 M with response times of 5 and 3 min, respectively, and with very good reversibility. The practical utility of the developed sensors was ensured by salicylate determination in Aspirin® and Aspocid®. Beyond the observed analytical performance, the present work aims not only to effectively apply Calixarene without derivatization, but also to estimate the strength of the size-dependent hydrogen bonding and comprehensively study the interaction mechanism.

Development and Validation of a Reversed-phase HPLC Method for Simultaneous Determination of Aspirin, Atorvastatin Calcium and Clopidogrel Bisulphate in Capsules

A simple, accurate, rapid and precise isocratic reversed-phase high-performance liquid chromatographic method has been developed and validated for simultaneous determination of aspirin, atorvastatin calcium and clopidogrel bisulphate in capsules. The chromatographic separation was carried out on an Inertsil ODS analytical column (150×4.6 mm; 5 μm) with a mixture of acetonitrile:phosphate buffer pH 3.0 adjusted with o-phosphoric acid (50:50, v/v) as mobile phase; at a flow rate of 1.2 ml/min. UV detection was performed at 235 nm. The retention times were 1.89, 6.6 and 19.8 min. for aspirin, atorvastatin calcium and clopidogrel bisulphate, respectively. Calibration plots were linear (r²>0.998) over the concentration range 5-30 μg/ml for atorvastatin calcium and 30-105 μg/ml for aspirin and clopidogrel bisulphate. The method was validated for accuracy, precision, specificity, linearity, and sensitivity. The proposed method was successfully used for quantitative analysis of capsules. No interference from any component of pharmaceutical dosage form was observed. Validation studies revealed that method is specific, rapid, reliable, and reproducible. The high recovery and low relative standard deviation confirm the suitability of the method for routine determination of aspirin, atorvastatin calcium and clopidogrel bisulphate in bulk drug and capsule dosage form.

Stable isotope dilution analysis of salicylic acid and hydroquinone in human skin samples by gas chromatography with mass spectrometric detection

A sensitive and accurate gas chromatographic-mass spectrometric (GC-MS) method has been developed for the quantitative determination of salicylic acid (SA) and hydroquinone (HQ) from human skin samples and cosmetic emulsions. Deuterium labeled SA-d(6) and HQ-d(6) were used as internal standards (IS). The samples were extracted with methanol, dried under nitrogen and derivatized with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA)+1% trimethylchlorosilane (TMCS). Quantification was performed in SIM mode with a limit of quantification (LOQ) of 50 ng ml(-1) for SA and 10 ng ml(-1) for HQ. The inter-day variation (R.S.D.) was less than 5% and the accuracy was better than 13.3% for both compounds. The recoveries from the different matrices ranged between 93.1 and 103.3% for SA, and 97.3 and 100.8% for HQ.

Semi-micro column high-performance liquid chromatography with UV detection for quantification of aspirin and salicylic acid and its application to patients' sera administered with low-dose enteric-coated aspirin

A simultaneous determination of aspirin (ASA) and its metabolite, salicylic acid (SA), in human serum by a semi-micro column HPLC-UV was developed. A relatively small size of serum sample (100 microL) containing ASA and SA was cleaned up by a simple solid phase extraction. A good separation of ASA and SA could be achieved within 25 min using a semi-micro ODS column with an eluent of MeOH/0.7 mm phosphoric acid solution (pH 2.5) = 50:50 (v/v). The calibration curves for ASA and SA showed good linearity (r = 0.999) with the detection limits 114 and 38 ng/mL at a signal-to-noise ratio of 3, respectively. ASA and SA in patients' sera administered with low-dose enteric-coated aspirin were determined, and the concentration ranges obtained for ASA and SA were 1.2-2.2 and 0.5-57.3 microg/mL, respectively.